ONCO Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Benzinga - Mentions: APDN ENTA VMD APLT ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 months ago - By: Onconetix, Inc.

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

2 months ago - By: Onconetix, Inc.

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

2 months ago - By: Onconetix, Inc.

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

2 months ago - By: Onconetix, Inc.

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

2 months ago - By: Benzinga - Mentions: RFL RPID HSDT SRRK ...

12 Health Care Stocks Moving In Monday's After-Market Session

2 months ago - By: Onconetix, Inc.

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

2 months ago - By: Onconetix, Inc.

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

5 months ago - By: Halper Sadeh LLC

ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders

5 months ago - By: Onconetix, Inc.

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

5 months ago - By: Onconetix, Inc.

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

6 months ago - By: Onconetix, Inc.

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

6 months ago - By: Onconetix, Inc.

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

6 months ago - By: Onconetix, Inc.

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

6 months ago - By: Onconetix, Inc.

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

7 months ago - By: Yahoo Finance - Mentions: NVDA INFA TSLA CRWD ...

Analyst Reiterates Buy on Nvidia (NVDA): ‘Best Positioned in AI’

7 months ago - By: Yahoo Finance - Mentions: PFBC

Onconetix receives additional delisting notice from Nasdaq

7 months ago - By: Yahoo Finance - Mentions: DHI PFBC HOUS

IAGG Attracted $1.9B Thursday as Markets Closed Flat

7 months ago - By: Yahoo Finance - Mentions: JPM XRX PFBC RRBI ...

Record ETF Launches Drive Active Fund Growth in 2025

7 months ago - By: Yahoo Finance - Mentions: JPM PFBC XRX RRBI ...

ONCONETIX INC (ONCO) Stock News

ONCO Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Friday's After-Market Session

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

12 Health Care Stocks Moving In Monday's After-Market Session

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Analyst Reiterates Buy on Nvidia (NVDA): ‘Best Positioned in AI’

Onconetix receives additional delisting notice from Nasdaq

IAGG Attracted $1.9B Thursday as Markets Closed Flat

Record ETF Launches Drive Active Fund Growth in 2025

Preferred Bank announces new $125M stock repurchase plan